Biocompatibility of ferritin-based nanoparticles as targeted MRI contrast agents.

Charlton JR, Pearl VM, Denotti AR, Lee JB, Swaminathan S, Scindia YM, Charlton NP, Baldelomar EJ, Beeman SC, Bennett KM. Biocompatibility of ferritin-based nanoparticles as targeted MRI contrast agents. Nanomedicine. 2016 08; 12(6):1735-45.

View in: PubMed

subject areas

Animals
Contrast Media
Ferritins
Horses
Iron
Liver
Magnetic Resonance Imaging
Male
Mice
Nanoparticles

authors with profiles

Kevin Bennett

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support